Cocrystal Pharma, Inc. Interest Expense in USD from Q2 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Cocrystal Pharma, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2010 to Q1 2024.
  • Cocrystal Pharma, Inc. Interest Expense for the quarter ending March 31, 2024 was -$220K.
  • Cocrystal Pharma, Inc. annual Interest Expense for 2023 was -$640K, a 32100% decline from 2022.
  • Cocrystal Pharma, Inc. annual Interest Expense for 2022 was $2K, a 50% decline from 2021.
  • Cocrystal Pharma, Inc. annual Interest Expense for 2021 was $4K, a 50% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)

Cocrystal Pharma, Inc. Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$220K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q3 2023 -$320K -$321K -32100% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$140K Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q3 2022 $1K $0 0% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q1 2022 $4K $1K $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $4K $0 -$2K -100% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 $6K $1K -$1K -50% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $7K $2K $0 0% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $7K $1K -$1K -50% Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $8K $2K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-23
Q3 2020 $2K -$3K -60% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-13
Q2 2020 $2K -$3K -60% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $2K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q3 2019 $5K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 $5K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2018 $32K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2013 -$3.34M -$1.39M -$1.13M -435% Oct 1, 2013 Dec 31, 2013 10-K 2014-03-31
Q3 2013 -$2.21M -$992K -$509K -105% Jul 1, 2013 Sep 30, 2013 10-Q 2013-11-18
Q2 2013 -$1.7M -$482K +$533K +52.5% Apr 1, 2013 Jun 30, 2013 10-Q 2013-08-15
Q1 2013 -$2.23M -$475K +$3M +86.3% Jan 1, 2013 Mar 31, 2013 10-Q 2013-05-10
Q4 2012 -$5.23M -$261K +$481K +64.8% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-31
Q3 2012 -$5.71M -$483K -$200K -70.4% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-18
Q2 2012 -$5.51M -$1.01M -$906K -834% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-15
Q1 2012 -$4.61M -$3.47M -$3.36M -3069% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 -$1.24M -$741K Oct 1, 2011 Dec 31, 2011 10-K 2013-04-01
Q3 2011 -$283K -$160K -130% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 -$109K -$14.2K -15% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-09-28
Q1 2011 -$110K Jan 1, 2011 Mar 31, 2011 10-Q/A 2012-10-02
Q3 2010 -$123K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-21
Q2 2010 -$94.5K Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-09-09

Cocrystal Pharma, Inc. Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$640K -$642K -32100% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $2K -$2K -50% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $4K -$4K -50% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-29
2020 $8K -$11K -57.9% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-23
2019 $19K -$39K -67.2% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-17
2018 $58K Jan 1, 2018 Dec 31, 2018 10-K 2020-03-27
2013 -$3.34M +$1.89M +36.1% Jan 1, 2013 Dec 31, 2013 10-K 2014-03-31
2012 -$5.23M -$3.99M -321% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-31
2011 -$1.24M -$804K -183% Jan 1, 2011 Dec 31, 2011 10-K 2013-04-01
2010 -$439K Jan 1, 2010 Dec 31, 2010 10-K 2012-04-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.